Celebrating a milestone! It's been one year since the FDA approved our treatment for Demodex blepharitis, marking a significant step forward in eye care. We are always happy to celebrate a win for patients, and as we reflect on this achievement, we're excited about the future and our ongoing commitment to improving the lives of those affected by this eyelid disease.
Wonderful!
Congrats to Team Tarsus!
So exciting!
Congrats!
Felix Perez, CEO Research Director
3moCongratulations on the milestone! It’s fantastic to see your dedication to advancing eye care and improving patient outcomes. Here’s to many more successes ahead! #EyeCare #PatientFirst